Abstract
Central venous catheters (CVCs) are frequently used as vascular access for patients who require hemodialysis, but infectious complications remain a major clinical problem. Specifically, catheter-related bloodstream infections (CRBSIs) have an adverse effect on survival, hospitalization, mortality, and the overall cost of care in this setting. The growing number of patients who require hemodialysis, combined with an increasing number of patients who cannot use any vascular access other than a CVC, stress the importance of strategies to prevent CRBSI. Various interventions aimed at reducing the incidence of CRBSI are available, but they have not yet been integrated into evidence-based, consensus guidelines. In this Review, the results from several CVC infection prevention studies—of patients from dialysis and nondialysis settings—are combined to outline a rational approach to CRBSI prevention. Prevention of intraluminal contamination of the CVC is pivotal and of proven efficacy, as are strict aseptic CVC insertion and handling protocols, use of chlorhexidine in alcohol solutions for skin cleansing, topical application of antimicrobial ointments, and antimicrobial lock solutions. Adherence to a meticulous catheter care protocol can achieve a CRBSI incidence well below one episode per 1,000 catheter days, even without the need for antimicrobial ointments or lock solutions.
Key Points
-
Central venous catheters (CVCs) are frequently used in patients on hemodialysis, but they are associated with high morbidity, mortality and health-care costs owing to infectious complications
-
Chlorhexidine in alcohol solutions for skin cleansing, topical application of antimicrobial ointments and antimicrobial lock solutions are proven to reduce the incidence of catheter-related bloodstream infections
-
Strict, aseptic CVC insertion, meticulous catheter care, and implementation of a catheter surveillance program are mandatory to reduce the incidence of catheter-related bloodstream infections
-
A catheter-related bloodstream infection rate below one episode per 1,000 catheter days is feasible and can be achieved without the use of antimicrobial agents
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Pisoni, R. L. et al. Vascular access use in Europe and the United States: results from the DOPPS. Kidney Int. 61, 305–316 (2002).
Dittmer, I. D., Sharp, D., McNulty, C. A., Williams, A. J. & Banks, R. A. A prospective study of central venous hemodialysis catheter colonization and peripheral bacteremia. Clin. Nephrol. 51, 34–39 (1999).
Engemann, J. J. et al. Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis. Infect. Control Hosp. Epidemiol. 26, 534–539 (2005).
Moist, L. M., Trpeski, L., Na, Y. & Lok, C. E. Increased hemodialysis catheter use in Canada and associated mortality risk: data from the Canadian organ replacement registry 2001–2004. Clin. J. Am. Soc. Nephrol. 3, 1726–1732 (2008).
Rayner, H. C. & Pisoni, R. L. The increasing use of hemodialysis catheters: evidence from the DOPPS on its significance and ways to reverse it. Semin. Dial. 23, 6–10 (2010).
Rabindranath, K. S. et al. Systematic review of antimicrobials for the prevention of haemodialysis catheter-related infections. Nephrol. Dial. Transplant. 24, 3763–3774 (2009).
Tokars, J. I., Miller, E. R. & Stein, G. New national surveillance system for hemodialysis-associated infections: initial results. Am. J. Infect. Control 30, 288–295 (2002).
Raad, I. et al. Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. J. Infect. Dis. 168, 400–407 (1993).
Bach, A. et al. Efficacy of silver-coating central venous catheters in reducing bacterial colonization. Crit. Care Med. 27, 515–521 (1999).
O'Grady, N. P. et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm. Rep. 51, 1–29 (2002).
Davies, D. G. et al. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 280, 295–298 (1998).
Asad, S. & Opal, S. M. Bench-to-bedside review: quorum sensing and the role of cell-to-cell communication during invasive bacterial infection. Crit. Care 12, 236 (2008).
Rasmussen, T. B. & Givskov, M. Quorum sensing inhibitors as anti-pathogenic drugs. Int. J. Med. Microbiol. 296, 149–161 (2006).
Pronovost, P. et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N. Engl. J. Med. 355, 2725–2732 (2006).
Beathard, G. A. & Urbanes, A. Infection associated with tunneled hemodialysis catheters. Semin. Dial. 21, 528–538 (2008).
Warren, D. K. et al. The effect of an education program on the incidence of central venous catheter-associated bloodstream infection in a medical ICU. Chest 126, 1612–1618 (2004).
Coopersmith, C. M. et al. The impact of bedside behavior on catheter-related bacteremia in the intensive care unit. Arch. Surg. 139, 131–136 (2004).
Beathard, G. A. Catheter management protocol for catheter-related bacteremia prophylaxis. Semin. Dial. 16, 403–405 (2003).
Pronovost, P. J. et al. Sustaining reductions in catheter related bloodstream infections in Michigan intensive care units: observational study. BMJ 340, c309 (2010).
Murphy, D. J. et al. Monitoring and reducing central line-associated bloodstream infections: a national survey of state hospital associations. Am. J. Med. Qual. 25, 255–260 (2010).
Rodriguez-Paz, J. M. & Pronovost, P. Prevention of catheter-related bloodstream infections. Adv. Surg. 42, 229–248 (2008).
Rubinson, L., Wu, A. W., Haponik, E. E. & Diette, G. B. Why is it that internists do not follow guidelines for preventing intravascular catheter infections? Infect. Control Hosp. Epidemiol. 26, 525–533 (2005).
Mermel, L. A. Prevention of intravascular catheter-related infections. Ann. Intern. Med. 132, 391–402 (2000).
Raad, I. I. et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect. Control Hosp. Epidemiol. 15, 231–238 (1994).
Chaiyakunapruk, N., Veenstra, D. L., Lipsky, B. A. & Saint, S. Chlorhexidine compared with povidone–iodine solution for vascular catheter-site care: a meta-analysis. Ann. Intern. Med. 136, 792–801 (2002).
McKee, R., Dunsmuir, R., Whitby, M. & Garden, O. J. Does antibiotic prophylaxis at the time of catheter insertion reduce the incidence of catheter-related sepsis in intravenous nutrition? J. Hosp. Infect. 6, 419–425 (1985).
Ranson, M. R., Oppenheim, B. A., Jackson, A., Kamthan, A. G. & Scarffe, J. H. Double-blind placebo controlled study of vancomycin prophylaxis for central venous catheter insertion in cancer patients. J. Hosp. Infect. 15, 95–102 (1990).
Tordoir, J. et al. EBPG on vascular access. Nephrol. Dial. Transplant. 22 (Suppl. 2), ii88–ii117 (2007).
Vanholder, R. et al. Diagnosis, prevention and treatment of haemodialysis catheter-related bloodstream infections (CRBSI): a position statement of the European Renal Best Practice (ERBP). NDT Plus 3, 234–246 (2010).
Randolph, A. G., Cook, D. J., Gonzales, C. A. & Brun-Buisson, C. Tunneling short-term central venous catheters to prevent catheter-related infection: a meta-analysis of randomized, controlled trials. Crit. Care Med. 26, 1452–1457 (1998).
Timsit, J. F. et al. Effect of subcutaneous tunneling on internal jugular catheter-related sepsis in critically ill patients: a prospective randomized multicenter study. JAMA 276, 1416–1420 (1996).
Atapour, A., Shahidi, S. & Sairafian, S. H. Does tunneling the temporary vascular access extend its lifetime? J. Res. Med. Sci. 11, 41–47 (2006).
Weijmer, M. C., Vervloet, M. G. & ter Wee, P. M. Prospective follow-up of a novel design haemodialysis catheter; lower infection rates and improved survival. Nephrol. Dial. Transplant. 23, 977–983 (2008).
Betjes, M. G. & van Agteren, M. Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution. Nephrol. Dial. Transplant. 19, 1546–1551 (2004).
Weijmer, M. C. et al. Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients. J. Am. Soc. Nephrol. 16, 2769–2777 (2005).
Deshpande, K. S. et al. The incidence of infectious complications of central venous catheters at the subclavian, internal jugular, and femoral sites in an intensive care unit population. Crit. Care Med. 33, 13–20 (2005).
Hamilton, H. C. & Foxcroft, D. R. Central venous access sites for the prevention of venous thrombosis, stenosis and infection in patients requiring long-term intravenous therapy. Cochrane Database of Systematic Reviews, Issue 3. Art. No.: CD004084. doi:10.1002/14651858.CD004084.pub2 (2007).
Parienti, J. J. et al. Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy: a randomized controlled trial. JAMA 299, 2413–2422 (2008).
Agarwal, A. K., Patel, B. M. & Haddad, N. J. Central vein stenosis: a nephrologist's perspective. Semin. Dial. 20, 53–62 (2007).
Hernández, D. et al. Subclavian vascular access stenosis in dialysis patients: natural history and risk factors. J. Am. Soc. Nephrol. 9, 1507–1510 (1998).
Vanholder, R. et al. Catheter-related blood stream infections (CRBSI): a European view. Nephrol. Dial. Transplant. 25, 1753–1756 (2010).
Luebke, M. A. et al. Comparison of the microbial barrier properties of a needleless and a conventional needle-based intravenous access system. Am. J. Infect. Control 26, 437–441 (1998).
Menyhay, S. Z. & Maki, D. G. Preventing central venous catheter-associated bloodstream infections: development of an antiseptic barrier cap for needleless connectors. Am. J. Infect. Control 36, S174.e1–S174.e5 (2008).
Blake, M. Update: catheter-related bloodstream infection rates in relation to clinical practice and needleless device type. Can. J. Infect. Control 23, 156–162 (2008).
Jean, G. et al. Risk factor analysis for long-term tunneled dialysis catheter-related bacteremias. Nephron 91, 399–405 (2002).
Gillies, D. et al. Gauze and tape and transparent polyurethane dressings for central venous catheters. Cochrane Database of Systematic Reviews, Issue 4. Art. No.: CD003827. doi:10.1002/14651858.CD003827 (2003).
Le Corre, I., Delorme, M. & Cournoyer, S. A prospective, randomized trial comparing a transparent dressing and a dry gauze on the exit-site of long term central venous catheters of hemodialysis patients. J. Vasc. Access 4, 56–61 (2003).
Camins, B. C. et al. A crossover intervention trial evaluating the efficacy of a chlorhexidine-impregnated sponge in reducing catheter-related bloodstream infections among patients undergoing hemodialysis. Infect. Control Hosp. Epidemiol. 31, 1118–1123 (2010).
Ho, K. M. & Litton, E. Use of chlorhexidine-impregnated dressing to prevent vascular and epidural catheter colonization and infection: a meta-analysis. J. Antimicrob. Chemother. 58, 281–287 (2006).
Jaffer, Y., Selby, N. M., Taal, M. W., Fluck, R. J. & McIntyre, C. W. A meta-analysis of hemodialysis catheter locking solutions in the prevention of catheter-related infection. Am. J. Kidney Dis. 233–241 (2008).
James, M. T. et al. Meta-analysis: antibiotics for prophylaxis against hemodialysis catheter-related infections. Ann. Intern. Med. 148, 596–605 (2008).
Yahav, D. et al. Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials. Clin. Infect. Dis. 47, 83–93 (2008).
Polaschegg, H. D. & Sodemann, K. Risks related to catheter locking solutions containing concentrated citrate. Nephrol. Dial. Transplant. 18, 2688–2690 (2003).
Punt, C. D. & Boer, W. E. Cardiac arrest following injection of concentrated trisodium citrate. Clin. Nephrol. 69, 317–318 (2008).
US Food and Drug Administration. FDA issues warning on tricitrasol dialysis catheter anticoagulant. FDA talk paper TOO-16 (14 April 2000).
Willicombe, M. K., Vernon, K. & Davenport, A. Embolic complications from central venous hemodialysis catheters used with hypertonic citrate locking solution. Am. J. Kidney Dis. 55, 348–351 (2010).
Moran, J. E. & Ash, S. R. Locking solutions for hemodialysis catheters; heparin and citrate—a position paper by ASDIN. Semin. Dial. 21, 490–492 (2008).
Grudzinski, L., Quinan, P., Kwok, S. & Pierratos, A. Sodium citrate 4% locking solution for central venous dialysis catheters—an effective, more cost-efficient alternative to heparin. Nephrol. Dial. Transplant. 22, 471–476 (2007).
Lok, C. E., Appleton, D., Bhola, C., Khoo, B. & Richardson, R. M. Trisodium citrate 4%—an alternative to heparin capping of haemodialysis catheters. Nephrol. Dial. Transplant. 22, 477–483 (2007).
Weijmer, M. C., Debets-Ossenkopp, Y. J., Van De Vondervoort, F. J. & ter Wee, P. M. Superior antimicrobial activity of trisodium citrate over heparin for catheter locking. Nephrol. Dial. Transplant. 17, 2189–2195 (2002).
Balestrino, D. et al. Eradication of microorganisms embedded in biofilm by an ethanol-based catheter lock solution. Nephrol. Dial. Transplant. 24, 3204–3209 (2009).
Takla, T. A., Zelenitsky, S. A. & Vercaigne, L. M. Effectiveness of a 30% ethanol/4% trisodium citrate locking solution in preventing biofilm formation by organisms causing haemodialysis catheter-related infections. J. Antimicrob. Chemother. 62, 1024–1026 (2008).
Bleyer, A. J., Mason, L., Russell, G., Raad, I. I. & Sherertz, R. J. A randomized, controlled trial of a new vascular catheter flush solution (minocycline-EDTA) in temporary hemodialysis access. Infect. Control Hosp. Epidemiol. 26, 520–524 (2005).
McCann, M. & Moore, Z. E. H. Interventions for preventing infectious complications in haemodialysis patients with central venous catheters. Cochrane Database of Systematic Reviews, Issue 1. Art. No.: CD006894. doi:10.1002/14651858.CD006894.pub2 (2010).
Johnson, D. W. et al. Randomized, controlled trial of topical exit-site application of honey (Medihoney) versus mupirocin for the prevention of catheter-associated infections in hemodialysis patients. J. Am. Soc. Nephrol. 16, 1456–1462 (2005).
Quadri, K. & Huraib, S. Manuka honey for central venous catheter exit-site care. Semin. Dial. 12, 397–398 (1999).
Kamalia, M. D., Haris, Y. A. & Zaki, S. M. Role of topical mupirocin as a prophylaxis in catheter related infection in haemodialysis patients. Int. Med. J. 11, 41–46 (2004).
Johnson, D. W. et al. A randomized controlled trial of topical exit-site mupirocin application in patients with tunnelled, cuffed haemodialysis catheters. Nephrol. Dial. Transplant. 17, 1802–1807 (2002).
Sesso, R. et al. Staphylococcus aureus prophylaxis in hemodialysis patients using central venous catheter: effect of mupirocin ointment. J. Am. Soc. Nephrol. 9, 1085–1092 (1998).
Levin, A., Mason, A. J., Jindal, K. K., Fong, I. W. & Goldstein, M. B. Prevention of hemodialysis subclavian vein catheter infections by topical povidone–iodine. Kidney Int. 40, 934–938 (1991).
Lok, C. E. et al. Hemodialysis infection prevention with polysporin ointment. J. Am. Soc. Nephrol. 14, 169–179 (2003).
Zakrzewska-Bode, A., Muytjens, H. L., Liem, K. D. & Hoogkamp-Korstanje, J. A. Mupirocin resistance in coagulase-negative staphylococci, after topical prophylaxis for the reduction of colonization of central venous catheters. J. Hosp. Infect. 31, 189–193 (1995).
Hurdle, J. G., O'Neill, A. J., Mody, L., Chopra, I. & Bradley, S. F. In vivo transfer of high-level mupirocin resistance from Staphylococcus epidermidis to methicillin-resistant Staphylococcus aureus associated with failure of mupirocin prophylaxis. J. Antimicrob. Chemother. 56, 1166–1168 (2005).
Miller, M. A., Dascal, A., Portnoy, J. & Mendelson, J. Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment. Infect. Control Hosp. Epidemiol. 17, 811–813 (1996).
Gilbert, R. E. & Harden, M. Effectiveness of impregnated central venous catheters for catheter related blood stream infection: a systematic review. Curr. Opin. Infect. Dis. 21, 235–245 (2008).
Veenstra, D. L., Saint, S., Saha, S., Lumley, T. & Sullivan, S. D. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. JAMA 281, 261–267 (1999).
Chatzinikolaou, I. et al. Antibiotic-coated hemodialysis catheters for the prevention of vascular catheter-related infections: a prospective, randomized study. Am. J. Med. 115, 352–357 (2003).
Dahlberg, P. J. et al. Subclavian hemodialysis catheter infections: a prospective, randomized trial of an attachable silver-impregnated cuff for prevention of catheter-related infections. Infect. Control Hosp. Epidemiol. 16, 506–511 (1995).
Trerotola, S. O. et al. Tunneled hemodialysis catheters: use of a silver-coated catheter for prevention of infection—a randomized study. Radiology 207, 491–496 (1998).
Vandecasteele, S. J., Boelaert, J. R. & De Vriese, A. S. Staphylococcus aureus infections in hemodialysis: what a nephrologist should know. Clin. J. Am. Soc. Nephrol. 4, 1388–1400 (2009).
Summers, S. A., Gupta, R. K., Clutterbuck, E. J., Laing, C. & Cooke, G. S. Haemodialysis catheter-associated infection: common pathogens in unusual places. Nephrol. Dial. Transplant. 20, 2287–2288 (2005).
von Eiff, C. et al. Nasal carriage as source of Stapylococcus aureus bacteremia. Study Group. N. Engl. J. Med. 344, 11–16 (2001).
Chow J. W. & Yu, V. L. Staphylococcus aureus nasal carriage in hemodialysis patients. Its role in infection and approaches to prophylaxis. Arch. Intern. Med. 149, 1258–1262 (1989).
Boelaert, J. R. et al. The influence of calcium mupirocin nasal ointment on the incidence of Staphylococcus aureus infections in haemodialysis patients. Nephrol. Dial. Transplant. 4, 278–281 (1989).
Boelaert, J. R. et al. Nasal mupirocin ointment decreases the incidence of Staphylococcus aureus bacteraemias in haemodialysis patients. Nephrol. Dial. Transplant. 8, 235–239 (1993).
van Rijen, M., Bonten, M., Wenzel, R. & Kluytmans, J. Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers. Cochrane Database of Systematic Reviews, Issue 4. Art. No.: CD006216. doi:10.1002/14651858.CD006216.pub2 (2008).
Yu, V. L. et al. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis. N. Engl. J. Med. 315, 91–96 (1986).
Boelaert, J. R. Staphylococcus aureus infection in haemodialysis patients. Mupirocin as a topical strategy against nasal carriage: a review. J. Chemother. 6 (Suppl. 2), 19–24 (1994).
Bloom, B. S., Fendrick, A. M., Chernew, M. E. & Patel, P. Clinical and economic effects of mupirocin calcium on preventing Staphylococcus aureus infection in hemodialysis patients: a decision analysis. Am. J. Kidney Dis. 27, 687–694 (1996).
Peña, C. et al. Staphylococcus aureus nasal carriage in patients on haemodialysis: role of cutaneous colonization. J. Hosp. Infect. 58, 20–27 (2004).
Scully, B. E., Briones, F., Gu, J. W. & Neu, H. C. Mupirocin treatment of nasal staphylococcal colonization. Arch. Intern. Med. 152, 353–356 (1992).
Doebbeling, B. N. et al. Long-term efficacy of intranasal mupirocin ointment. A prospective cohort study of Staphylococcus aureus carriage. Arch. Intern. Med. 154, 1505–1508 (1994).
Doebbeling, B. N. et al. Elimination of Staphylococcus aureus nasal carriage in health care workers: analysis of six clinical trials with calcium mupirocin ointment. The mupirocin collaborative study group. Clin. Infect. Dis. 17, 466–474 (1993).
Kluytmans, J. A., Manders, M. J., van Bommel, E. & Verbrugh, H. Elimination of nasal carriage of Staphylococcus aureus in hemodialysis patients. Infect. Control Hosp. Epidemiol. 17, 793–797 (1996).
Watanakunakorn, C. et al. The efficacy of mupirocin ointment and chlorhexidine body scrubs in the eradication of nasal carriage of Staphylococcus aureus among patients undergoing long-term hemodialysis. Am. J. Infect. Control 20, 138–141 (1992).
Holton, D. L., Nicolle, L. E., Diley, D. & Bernstein, K. Efficacy of mupirocin nasal ointment in eradicating Staphylococcus aureus nasal carriage in chronic haemodialysis patients. J. Hosp. Infect. 17, 133–137 (1991).
Sedlacek, M., Gemery, J. M., Cheung, A. L., Bayer, A. S. & Remillard, B. D. Aspirin treatment is associated with a significantly decreased risk of Staphylococcus aureus bacteremia in hemodialysis patients with tunneled catheters. Am. J. Kidney Dis. 49, 401–408 (2007).
Pronovost, P. Interventions to decrease catheter-related bloodstream infections in the ICU: the keystone intensive care unit project. Am. J. Infect. Control 36, S171.e1–S171.e5 (2008).
Power, A. et al. Sodium citrate versus heparin catheter locks for cuffed central venous catheters: a single-center randomized controlled trial. Am. J. Kidney Dis. 53, 1034–1041 (2009).
Abbas, S. A. et al. Effect of antimicrobial locks for tunneled hemodialysis catheters on bloodstream infection and bacterial resistance: a quality improvement report. Am. J. Kidney Dis. 53, 492–502 (2009).
Lemaire, X. et al. Analysis of risk factors for catheter-related bacteremia in 2000 permanent dual catheters for hemodialysis. Blood Purif. 28, 21–28 (2009).
Acknowledgements
The author thanks Dr. van Agteren and the members of the Quality Committee of the Dutch Nephrology Association for their critical reading of the manuscript. C. P. Vega, University of California, Irvine, CA, is the author of and is solely responsible for the content of the learning objectives, questions and answers of the Medscape, LLC-accredited continuing medical education activity associated with this article.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Betjes, M. Prevention of catheter-related bloodstream infection in patients on hemodialysis. Nat Rev Nephrol 7, 257–265 (2011). https://doi.org/10.1038/nrneph.2011.28
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2011.28
This article is cited by
-
Sodium bicarbonate is a potential alternative to classic heparin as a lock solution for non-tunneled dialysis catheters: a result from the prospective randomized BicarbLock trial
International Urology and Nephrology (2023)
-
Substitution of citrate with tissue plasminogen activator (rt-PA) for catheter lock does not improve patency of tunnelled haemodialysis catheters in a randomised trial
BMC Nephrology (2021)
-
Slippery liquid infused fluoropolymer coating for central lines to reduce catheter associated clotting and infections
Scientific Reports (2020)
-
Ethanol lock is effective on reducing the incidence of tunneled catheter-related bloodstream infections in hemodialysis patients: a systematic review and meta-analysis
International Urology and Nephrology (2018)
-
Surveillance of Dialysis Events: one-year experience at 33 outpatient hemodialysis centers in China
Scientific Reports (2017)